Showing 1431-1440 of 3137 results for "".
Attention, Please! Why Dermatologists Need to Confront Burnout
https://practicaldermatology.com/topics/practice-management/attention-please-why-dermatologists-need-to-confront-burnout/20557/Raising awareness of the problem is essential to finding a solution.Lead Psoriasis Patients Along the Path to Clearance
https://practicaldermatology.com/topics/psoriasis/PD0209_01-php/22873/With so many effective therapies now available, dermatologists must be prepared to guide their patients to the right treatment for their specific presentation.Scientifically Speaking: Investing in Innovation with Humberto Antunes
https://practicaldermatology.com/series/scientifically-speaking/scientifically-speaking-investing-in-innovation-with-humberto-antunes/20128/With decades of experience in dermatology and aesthetics, Humberto Antunes has helped to identify some key innovations in the field. Now part of Gore Range Capital, he continues to look for the next game-changer. He discusses his experience and shares insights on the specialties with host Joel L. CoJames Del Rosso, DO: Thoughts on the FDA Citizen's Petition for Acne Products with Benzoyl Peroxide (BPO)
https://practicaldermatology.com/topics/acne-rosacea/james-del-rosso-do-thoughts-fda-citizens-petition-acne-products-benzoyl-peroxide-bpo/24173/James Q. Del Rosso, DO, a dermatologist and president of The American Acne and Rosacea Society (AARS), weighs in on a recent report from Valisure which finds that benzene can form at elevated levels in products for acne that contain benzoyl peroxide (BPO). The interview was conducted by Neal Bhatia,Workplace Diversity: Spotting Opportunities and Overcoming Challenges
https://practicaldermatology.com/topics/practice-management/workplace-diversity-spotting-opportunities-and-overcoming-challenges/23762/An expert on workplace diversity and class bias shares insights to help all organizations improve.Rebooting the C. acnes Narrative
https://practicaldermatology.com/topics/acne-rosacea/rebooting-the-ic-acnesi-narrative/23623/What Does Efficacy Cost? Evidence for Relative Cost-Effectiveness of Biologic Therapies for Psoriasis
https://practicaldermatology.com/topics/psoriasis/what-does-efficacy-cost-evidence-for-relative-cost-effectiveness-of-biologic-therapies-for-psoriasis/23128/Despite high costs, evidence suggests that biologics are cost-effective options for moderate to severe psoriasis because of their efficacy.New Frontiers in Neurotoxins
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/new-frontiers-in-neurotoxins/21638/Recent innovations offer patients greater variety and potentially better outcomes.Letter to the Editor
https://practicaldermatology.com/columns/letter-to-the-editor/letter-to-the-editor-2/23905/Cosmeceuticals: A Clinician's Guide to Science, Selection, Marketing, and Dispensing
https://practicaldermatology.com/topics/general-topics/cosmeceuticals-a-clinicians-guide-to-science-selection-marketing-and-dispensing/22007/Experienced physicians describe dispensing strategies that provide the greatest benefit to the patient and the practice.